Prisma Health Pediatric Endocrinology

Columbia, South Carolina 29203

1 studies enrolling now · 2 studies all time

What they study most

Central Precocious Puberty, Type 2 Diabetes

Studies at this site

• A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) — Recruiting now
• A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial) — Running, not enrolling